EGFR and glioblastoma: The co-occurrence of CDK6 and MET alterations with EGFR Amp was consistent in all GBM, histological GBM and histologic grade 2 and 3 IDH-wildtype diffuse astrocytic gliomas, whereas no possibly correlated genetic alterations were found in molecular GBM.